UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000018553 |
|---|---|
| Receipt number | R000021399 |
| Scientific Title | Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest |
| Date of disclosure of the study information | 2015/10/01 |
| Last modified on | 2016/04/02 14:10:18 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest
Acronym
Efficiency of IGF-1 therapy for cerebral ischemia by CPA
Scientific Title
Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest
Scientific Title:Acronym
Efficiency of IGF-1 therapy for cerebral ischemia by CPA
Region
| Japan |
Condition
Condition
Cerebral ischemia by cardiopulmonary arrest
Classification by specialty
| Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Inhospital mortality
Key secondary outcomes
Neurologic outcome
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
insulin-like growth factor 1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 15 | years-old | < |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
cardiopulmonary arrest
Key exclusion criteria
trauma
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Naoya Matsuda |
Organization
Yokohama City Minato Red Cross Hospital
Division name
Emergency and critical care center
Zip code
Address
3-12-1 Shinyamashita, Naka-ku, Yokohama city, Japan
TEL
045-628-6100
n.matsuda.shinshu@gmail.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Naoya Matsuda |
Organization
Yokohama City Minato Red Cross Hospital
Division name
Emergency and critical care center
Zip code
Address
3-12-1 Shinyamashita, Naka-ku, Yokohama city, Japan
TEL
045-628-6100
Homepage URL
n.matsuda.shinshu@gmail.com
Sponsor or person
Institute
Emergency and critical care center
Institute
Department
Personal name
Funding Source
Organization
TEIJIN Pharma
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
横浜市立みなと赤十字病院（神奈川県）
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2015 | Year | 08 | Month | 05 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2016 | Year | 10 | Month | 01 | Day |
Date of closure to data entry
| 2016 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
| 2016 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2017 | Year | 03 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2015 | Year | 08 | Month | 05 | Day |
Last modified on
| 2016 | Year | 04 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021399
